Skip to main content
Clinical Trials/ITMCTR2023000037
ITMCTR2023000037RecruitingUnknown

Heading needle training intervenes dysphagia in apoplexy decubation:A randomized controlled trial

Guangzhou University of Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 100 (—)
Sex
All

Inclusion Criteria

  • (1)According to the Key Points of Diagnosis of Major Cerebrovascular Diseases in China 2019 and the Chinese Expert Consensus of Monitoring Stroke, the symptoms of stroke meet the diagnostic criteria. Similarly, the Expert Consensus of Assessment and Treatment of Swallowing Disorders in China (2017 edition) confirms that swallowing disorder meets the diagnostic criteria.Stroke meets the diagnostic criteria in the TCM Industry standard of China's Diagnosis Basis, Syndrome Classification and Efficacy Evaluation of Stroke and the Certificate Diagnosis and Efficacy Standards for Internal Medicine of Traditional Chinese Medicine. Additionally, dysphagia is commonly caused by a stroke.
  • (2)In the recovery phase of stroke, onset occurred between 1 month and six months ago.
  • (3)Water Swallow Test (WST) at levels 3 to 5.
  • (4)Stable vital signs, absence of severe cognitive impairments or receptive aphasia affecting command comprehension, and a No Cognitive Impairment assessment on the Mini-Mental State Examination (MMSE).
  • (5)Good compliance willingness of both patients and family members to cooperate with the research treatment plan and follow-up.
  • (6)Comprehensive understanding of the risks and benefits of treatment by research subjects and their families, voluntary participation in the trial, and signing informed consent forms.

Exclusion Criteria

  • (1) Combined with other conditions affecting swallowing function, such as esophageal tumors, Guillain-Barré syndrome, head and neck tumors, etc.; or concurrent with situations impacting swallowing function, such as undergoing tracheostomy or water restriction due to medical reasons.
  • (2) Accompanied by severe systemic diseases like cardiovascular, pulmonary, hepatic, renal disorders, malignancies, or with abnormal coagulation function, hematologic disorders, or cachexia.
  • (3) History of two or more strokes.
  • (4) Anticipated survival of less than 3 months.
  • (5) Existing or suspected cases of aspirational pneumonia.
  • (6) Pregnant or lactating women.
  • (7) Currently participating in other clinical trials or having received other acupuncture treatments that could affect the present study.

Investigators

Similar Trials